Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
McKesson
McKinsey
Moodys
Merck
Harvard Business School

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VILAZODONE HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Vilazodone Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00285376 Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response Completed Genaissance Pharmaceuticals Phase 3 2006-02-01 This study is designed to determine the safety and effectiveness of vilazodone for major depressive disorder and to discover genetic markers associated with response. This study will enroll approximately 400 patients.
NCT00290914 Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder Completed Pharmacology Research Institute Phase 2 1969-12-31 The purpose is to evaluate the safety and usefulness of the investigational drug, vilazodone in depression.
NCT00644358 A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD) Completed Forest Laboratories Phase 3 2007-12-01 This open label 52-week clinical trial is designed to assess the safety and tolerability of vilazodone and to analyze genetic markers of response to vilazodone in adult patients diagnosed with MDD. This study will enroll approximately 600 patients.
NCT00683592 Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD) Completed Forest Laboratories Phase 3 2008-03-01 This randomized, double-blind, placebo-controlled, multicenter, 8-week, clinical trial is designed to assess the efficacy and safety of vilazodone and to evaluate genetic biomarkers of treatment response associated with vilazodone use in adult patients diagnosed with MDD by the DSM-IV-TR criteria.
NCT01473381 Safety and Efficacy of Vilazodone in Major Depressive Disorder Completed Forest Laboratories Phase 4 2011-12-01 The purpose of this study was to evaluate the efficacy, safety, and tolerability of 2 fixed dose levels of vilazodone compared to placebo in patients with major depressive disorder.
NCT01473394 Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder Completed Forest Laboratories Phase 4 2011-12-01 The purpose of this study was to further characterize the efficacy, safety, and tolerability of a single fixed dose level of vilazodone compared to placebo in patients with major depressive disorder.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Vilazodone Hydrochloride

Condition Name

Condition Name for Vilazodone Hydrochloride
Intervention Trials
Major Depressive Disorder 13
Generalized Anxiety Disorder 3
Marijuana Dependence 1
Depression 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Vilazodone Hydrochloride
Intervention Trials
Depression 16
Depressive Disorder, Major 15
Depressive Disorder 15
Disease 14
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Vilazodone Hydrochloride

Trials by Country

Trials by Country for Vilazodone Hydrochloride
Location Trials
United States 226
Ukraine 5
Serbia 4
Canada 4
Finland 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Vilazodone Hydrochloride
Location Trials
California 14
Texas 12
Florida 12
New York 11
Tennessee 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Vilazodone Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Vilazodone Hydrochloride
Clinical Trial Phase Trials
Phase 4 9
Phase 3 10
Phase 2 4
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Vilazodone Hydrochloride
Clinical Trial Phase Trials
Completed 20
Recruiting 3
Terminated 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Vilazodone Hydrochloride

Sponsor Name

Sponsor Name for Vilazodone Hydrochloride
Sponsor Trials
Forest Laboratories 19
University of California, Los Angeles 1
Thomas Jefferson University 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Vilazodone Hydrochloride
Sponsor Trials
Industry 20
Other 14
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Johnson and Johnson
Boehringer Ingelheim
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.